Literature DB >> 8409541

Assessment of viability after myocardial infarction. Clinical relevance and methodological problems.

G Fragasso1, A Margonato, S L Chierchia.   

Abstract

In patients with myocardial infarction, the distinction between reversible and irreversible ventricular dysfunction has important clinical implications since dysfunctional but viable myocardium will resume contraction following revascularization. Various methods have been developed for the identification of potentially reversible myocardial dysfunction. Thallium reinjection, immediately after stress-redistribution imaging, may provide evidence of myocardial viability by demonstrating thallium uptake in regions with apparently 'irreversible' defects. Hypoperfused, hypocontractile segments may recover function after revascularization, when exhibiting increased 18F-fluoro-deoxy-glucose uptake on positron emission tomography. Improved contractile function by selective beta 1 adrenergic stimulation with low dose dobutamine may also indicate the presence of viable tissue and predict subsequent improvement upon restoration of adequate flow. Finally, exercise-induced ST segment elevation on leads exploring a recent myocardial infarction has also been shown to indicate the presence of viable, potentially salvageable tissue. We discuss here these and several other methods that have been proposed for the detection of residual myocardial viability. Their advantages, limitations, and relevance to clinical problems are also discussed.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8409541     DOI: 10.1007/bf01143141

Source DB:  PubMed          Journal:  Int J Card Imaging        ISSN: 0167-9899


  44 in total

1.  Metabolic responses of hibernating and infarcted myocardium to revascularization. A follow-up study of regional perfusion, function, and metabolism.

Authors:  T H Marwick; W J MacIntyre; A Lafont; J J Nemec; E E Salcedo
Journal:  Circulation       Date:  1992-04       Impact factor: 29.690

2.  Assessment of residual tissue viability by exercise testing in recent myocardial infarction: comparison of the electrocardiogram and myocardial perfusion scintigraphy.

Authors:  A Margonato; C Ballarotto; F Bonetti; A Cappelletti; M Sciammarella; D Cianflone; S L Chierchia
Journal:  J Am Coll Cardiol       Date:  1992-04       Impact factor: 24.094

3.  Autoregulation of the coronary circulation.

Authors:  W P Dole
Journal:  Prog Cardiovasc Dis       Date:  1987 Jan-Feb       Impact factor: 8.194

4.  Determinants of reversible asynergy. The native coronary circulation.

Authors:  V S Banka; M M Bodenheimer; R H Helfant
Journal:  Circulation       Date:  1975-11       Impact factor: 29.690

5.  Regional metabolic abnormality in relation to perfusion and wall motion in patients with myocardial infarction: assessment with emission tomography using an iodinated branched fatty acid analog.

Authors:  N Tamaki; M Kawamoto; Y Yonekura; Y Fujibayashi; N Takahashi; J Konishi; R Nohara; H Kambara; C Kawai; K Ikekubo
Journal:  J Nucl Med       Date:  1992-05       Impact factor: 10.057

6.  Technetium-99m isonitrile myocardial uptake at rest. II. Relation to clinical markers of potential viability.

Authors:  T P Rocco; V Dilsizian; H W Strauss; C A Boucher
Journal:  J Am Coll Cardiol       Date:  1989-12       Impact factor: 24.094

7.  Noninvasive estimation of regional myocardial oxygen consumption by positron emission tomography with carbon-11 acetate in patients with myocardial infarction.

Authors:  M N Walsh; E M Geltman; M A Brown; C G Henes; C J Weinheimer; B E Sobel; S R Bergmann
Journal:  J Nucl Med       Date:  1989-11       Impact factor: 10.057

8.  Preoperative prediction of reversible myocardial asynergy by postexercise radionuclide ventriculography.

Authors:  A Rozanski; D Berman; R Gray; G Diamond; M Raymond; J Prause; J Maddahi; H J Swan; J Matloff
Journal:  N Engl J Med       Date:  1982-07-22       Impact factor: 91.245

9.  Evaluation of myocardial metabolism, with N-13- and C-11-labeled amino acids and positron computed tomography.

Authors:  E Henze; H R Schelbert; J R Barrio; J E Egbert; H W Hansen; N S MacDonald; M E Phelps
Journal:  J Nucl Med       Date:  1982-08       Impact factor: 10.057

10.  Myocardial metabolism of fluorodeoxyglucose compared to cell membrane integrity for the potassium analogue rubidium-82 for assessing infarct size in man by PET.

Authors:  K L Gould; K Yoshida; M J Hess; M Haynie; N Mullani; R W Smalling
Journal:  J Nucl Med       Date:  1991-01       Impact factor: 10.057

View more
  1 in total

1.  Assessment of myocardial viability by dynamic tomographic iodine 123 iodophenylpentadecanoic acid imaging: comparison with rest-redistribution thallium 201 imaging.

Authors:  A S Iskandrian; J Powers; V Cave; V Wasserleben; D Cassell; J Heo
Journal:  J Nucl Cardiol       Date:  1995 Mar-Apr       Impact factor: 5.952

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.